The Multicentre Selective Lymphadenectomy Trial - 3

NANot yet recruitingINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

August 31, 2030

Study Completion Date

August 31, 2040

Conditions
Cutaneous Melanoma, Stage III
Interventions
PROCEDURE

Index lymph node resection

The largest lymph node affected with melanoma

PROCEDURE

Therapeutic lymph node dissection

Removal of all nodes in the melanoma affected lymph node basin

Trial Locations (6)

2065

Melanoma Institute Australia, Wollstonecraft

90025

Cedars-Sinai Medical Centre, Los Angeles

Unknown

Sunnybrook Health Sciences Centre, Toronto

San Maria della Misericordia Hospital, Perugia

North Shore Hospital, Takapuna

The Royal Marsden, London

All Listed Sponsors
lead

Melanoma Institute Australia

OTHER